Major changes to P&R process in Spain expected in 2021
Patricia Lacruz, Head of the Dirección General de Cartera Básica de Servicios del Sistema Nacional de Salud y Farmacia (DGCBSF), … read more »
Italy’s reimbursement reforms leave questions
Reforms proposed in 2019, designed to relate Italian pricing and reimbursement decisions to the benefit offered by a medicine, have … read more »
NICE introduces interim process changes
The National Institute for Health and Care Excellence (NICE) has made an alteration to its technology appraisal (TA) process as … read more »
NICE to restart publishing guidance not related to COVID-19 from 1 June
The National Institute for Health and Care Excellence (NICE) have announced that from 1 June they will restart publishing guidance … read more »
SMC and AWMSG call off meetings
To protect the health of stakeholders, and to ensure continuity of service, the Scottish Medicines Consortium (SMC) and the All-Wales … read more »
*Updated* NICE shifts focus as COVID-19 takes priority
The National Institute for Health and Care Excellence (NICE) has written to bodies such as the Ethical Medicines Industry Group … read more »
Office for Health Economics examines the ethics of ultra-orphan appraisals
The Office for Health Economics (OHE) has released a report in which it examines the ethics behind the way medicines … read more »
EFPIA sounds warning on EU joint HTA
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has published a statement expressing its concerns over the current proposal … read more »
SMC announces November 2019 decisions
The Scottish Medicines Consortium (SMC) has published its medicine recommendations for November 2019 including a new combination breast cancer treatment. … read more »
EUnetHTA publishes REQueST Tool and its vision paper
EUnetHTA has published its Registry Evaluation and Quality Standards Tool (REQueST) and vision paper which aims to support HTA organisations … read more »
